Univ Paris Est Creteil, INSERM, IMRB, Creteil, France.
Cytometry core facility, Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS3633, Paris, France.
Nat Commun. 2021 May 17;12(1):2860. doi: 10.1038/s41467-021-22842-5.
Bone regenerates by activation of tissue resident stem/progenitor cells, formation of a fibrous callus followed by deposition of cartilage and bone matrices. Here, we show that mesenchymal progenitors residing in skeletal muscle adjacent to bone mediate the initial fibrotic response to bone injury and also participate in cartilage and bone formation. Combined lineage and single-cell RNA sequencing analyses reveal that skeletal muscle mesenchymal progenitors adopt a fibrogenic fate before they engage in chondrogenesis after fracture. In polytrauma, where bone and skeletal muscle are injured, skeletal muscle mesenchymal progenitors exhibit altered fibrogenesis and chondrogenesis. This leads to impaired bone healing, which is due to accumulation of fibrotic tissue originating from skeletal muscle and can be corrected by the anti-fibrotic agent Imatinib. These results elucidate the central role of skeletal muscle in bone regeneration and provide evidence that skeletal muscle can be targeted to prevent persistent callus fibrosis and improve bone healing after musculoskeletal trauma.
骨骼通过激活组织驻留的干细胞/祖细胞来再生,形成纤维性骨痂,随后沉积软骨和骨基质。在这里,我们表明,位于骨骼附近骨骼肌中的间充质祖细胞介导了对骨损伤的初始纤维反应,并且还参与了软骨和骨形成。联合谱系和单细胞 RNA 测序分析表明,在骨折后,骨骼肌间充质祖细胞在参与软骨形成之前先采用纤维发生命运。在骨骼和骨骼肌同时受伤的多发性创伤中,骨骼肌间充质祖细胞表现出改变的纤维发生和软骨发生。这导致骨愈合受损,这是由于源自骨骼肌的纤维性组织的积累引起的,并且可以通过抗纤维化药物伊马替尼来纠正。这些结果阐明了骨骼肌在骨骼再生中的核心作用,并提供了证据表明可以针对骨骼肌来预防持续的骨痂纤维化并改善肌肉骨骼创伤后的骨愈合。